Drip-and-ship toward mothership model for mechanical thrombectomy during COVID-19 pandemic: a retrospective analysis Matteo PaolucciSara BiguzziMarco Longoni COVID-19 31 January 2022 Pages: 1 - 7
The future of neurology after the COVID-19 pandemic according to neurology residents Tommaso ErcoliFrancesco Barbatoon behalf of SIgN COVID-19 13 October 2022 Pages: 9 - 12
Safety of COVID-19 vaccine in patients with epilepsy: a meta-analysis Qian ZhengPengfei MaZhanhui Feng COVID-19 15 October 2022 Pages: 13 - 17
Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease Madhumitha KattaBlessy Aksa MathewAnjana Munshi Review Article 06 September 2022 Pages: 19 - 36
The use of dual antiplatelet therapy for ischemic cerebrovascular events Francesco MeleClaudia GendariniLeonardo Pantoni Review Article Open access 17 September 2022 Pages: 37 - 43
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective Giacomo LusMarco André BassanoLuigi Maria Edoardo Grimaldi Review Article Open access 17 September 2022 Pages: 45 - 58
The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis Nader SalariRazie HasheminezhadMasoud Mohammadi Review Article 17 September 2022 Pages: 59 - 66
The prevalence of restless legs syndrome (RLS) in patients with multiple sclerosis (MS): a systematic review and meta-analysis—an update Alireza ZaliMahsa MotavafOmid Mirmosayyeb Review Article 05 September 2022 Pages: 67 - 82
Heart rate variability and fatigue in MS: two parallel pathways representing disseminated inflammatory processes? Guadalupe GarisMichael HauptsHelmut Hildebrandt Review Article Open access 20 September 2022 Pages: 83 - 98
Role of neurotransmitters in immune-mediated inflammatory disorders: a crosstalk between the nervous and immune systems Mojgan OshaghiMasoumeh Kourosh-AramiMaryam Roozbehkia Review Article 28 September 2022 Pages: 99 - 113
Clonazepam for the management of sleep disorders Alberto RaggiMaria Paola MogaveroRaffaele Ferri Review Article 16 September 2022 Pages: 115 - 128
Persistent positional perceptual dizziness in clinical practice: a scoping review Soumyajit DasChandra Sekhar AnnamRamesh Seepana Review Article 22 August 2022 Pages: 129 - 135
Neurology of cancer immunotherapy Amedeo De GradoFederica CenciniAlberto Priori Review Article Open access 16 September 2022 Pages: 137 - 148
Inflammation, metabolic dysregulation and environmental neurotoxins and risk of cognitive decline and impairment in midlife Carla R. SchubertMary E. FischerKaren J. Cruickshanks Original Article 17 September 2022 Pages: 149 - 157
Optimal MoCA cutoffs for detecting biologically-defined patients with MCI and early dementia Ciro Rosario IlardiAlina MenichelliPaolo Manganotti Original Article Open access 28 September 2022 Pages: 159 - 170
The microstructural abnormalities of cingulum was related to patients with mild cognitive impairment: a diffusion kurtosis imaging study Yueyang LiuDongtao LiuLichun Zhou Original Article Open access 28 September 2022 Pages: 171 - 180
Gait performance and non-motor symptoms burden during dual-task condition in Parkinson’s disease Meimei ZhangYawen GanYumei Zhang Original Article 20 September 2022 Pages: 181 - 190
REM sleep behavior disorder correlates with constipation in de novo Chinese Parkinson’s disease patients Yajing ChenQian XuWei Chen Original Article 13 September 2022 Pages: 191 - 197
Challenging functional connectivity data: machine learning application on essential tremor recognition Valeria SaccàFabiana NovellinoAldo Quattrone Original Article 20 September 2022 Pages: 199 - 207
Sleep disorders in Wilson’s disease: a questionnaire study Zhifei YouHui XuZhengchen You Original Article 15 September 2022 Pages: 209 - 214
Prevalence and the age of onset patterns of stroke in Jiangsu Province, China Chenlu HeQian ChenXunbao Zhang Original Article 03 October 2022 Pages: 215 - 227
The PRESTO study: awareness of stroke symptoms and time from onset to intervention Ilaria GandogliaErika SchirinziMassimo Del Sette Original Article 03 October 2022 Pages: 229 - 236
The HALP (hemoglobin, albumin, lymphocyte, and platelet) score is associated with early-onset post-stroke cognitive impairment Minjie XuLingli ChenWenwei Ren Original Article 04 October 2022 Pages: 237 - 245
Non-stenosing carotid artery plaques in embolic stroke of undetermined source: a retrospective analysis Ammar JumahHassan Aboul NourDaniel Miller Original Article 27 September 2022 Pages: 247 - 252
Predictors of 30-day mortality using machine learning approach following carotid endarterectomy Ahmed MohamedAshfaq ShuaibNida Fatima Original Article 15 September 2022 Pages: 253 - 261
Fibrocartilaginous embolism: a rare cause leading to spinal cord infarction? Elisa Francesca CiceriValentina OpancinaLuisa Chiapparini Original Article 17 September 2022 Pages: 263 - 271
Rapid, non-contact multifocal visual assessment in multiple sclerosis Ted MaddessJoshua P. van KleefChristian J. Lueck Original Article Open access 13 September 2022 Pages: 273 - 279
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina Juan I. RojasAgustín PappollaEdgar Carnero Contentti Original Article 27 September 2022 Pages: 281 - 286
Power spectrum analysis and outcomes of non-convulsive status epilepticus: a single-center study Jianhua ChenLiri JinYan Huang Original Article 30 September 2022 Pages: 287 - 295
Cannabis-based magistral formulation is highly effective as an adjuvant treatment in drug-resistant focal epilepsy in adult patients: an open-label prospective cohort study Cristian Eduardo Navarro Original Article 21 September 2022 Pages: 297 - 304
Functional connectivity alterations in migraineurs with Alice in Wonderland syndrome Claudia PiervincenziNikolaos PetsasPatrizia Pantano Original Article 17 September 2022 Pages: 305 - 317
Aseptic meningitis in Fabry disease due to a novel GLA variant: an expanded phenotype? Paulo Ribeiro NóbregaJoão Lucas Araújo MoraisFernanda Martins Maia Carvalho Original Article 12 September 2022 Pages: 319 - 327
Use of MFM-20 to monitor SMA types 1 and 2 patients treated with nusinersen Laure Le GoffAndreea SeferianCarole Vuillerot Original Article 29 September 2022 Pages: 329 - 337
A true isolated cognitive relapse in multiple sclerosis Valeria PozzilliAlessandro CrucianiVincenzo Di Lazzaro Brief Communication 08 October 2022 Pages: 339 - 342
Pediatric tumefactive multiple sclerosis case (with baló-like lesions), diagnostic and treatment challenges Christina KamariEmmanouil GalanakisPelagia Vorgia Brief Communication Open access 29 September 2022 Pages: 343 - 345
Stroke-like presentation of autoimmune chorea with positive anti-Yo and anti-MOG antibodies: a case report Manli RenQinming Zhou Brief Communication 25 October 2022 Pages: 347 - 349
Peripheral nerve involvement in wild-type transthyretin amyloidosis Marta CampagnoloMario CacciavillaniChiara Briani Brief Communication 19 October 2022 Pages: 351 - 354
Letter to the Editor: does erythropoietin affect the outcome and complication rates of patient with traumatic brain injury? A pooled analysis Qingyong ZhengJianguo XuXiaofeng Luo Letter to the Editor 28 August 2022 Pages: 355 - 356
Reversible cerebral venous dilatation syndrome associated to cannabis consumption: Expanding the spectrum of cerebrovascular dysregulation disorders? Simone RossiGian Maria AsioliLuca Spinardi Letter to the Editor 19 September 2022 Pages: 357 - 359
Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod Matheus Bernardon MorillosPaulo Henrique Pires de AguiarAlessandro Finkelsztejn Letter to the Editor 29 August 2022 Pages: 361 - 363
A rare case of meningomyelitis: infective or autoimmune etiology? Sampurna ChowdhuryRajesh Kumar SinghManjari Tripathi Letter to the Editor 21 September 2022 Pages: 365 - 368
Bilateral hearing loss preceding rhomboencephalitis – a hint for Kelch-like 11 syndrome David KrivitskiYifat AlcalayAvi Gadoth Letter to the Editor 16 September 2022 Pages: 369 - 372
Successful treatment of paroxysmal painful tonic spasms with carbamazepine in a patient with hypertrophic olivary degeneration Alessia FioreIrene FlorindoElisabetta Chierici Letter to the Editor 09 September 2022 Pages: 373 - 375
Carbamazepine-induced convulsive status epilepticus in benign adult familial myoclonic epilepsy: a case report Tatsuya UenoAtsuko KatagaiMasahiko Tomiyama Letter to the Editor 31 August 2022 Pages: 377 - 379
Rolandic epilepsy with paroxysmal exercise-induced dystonia and writer’s cramp: a case report Sareh HosseinpourAli Reza TavasoliMaziar Emamikhah Letter to the Editor 10 September 2022 Pages: 381 - 384
Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: a pragmatic multicenter, prospective, randomized, controlled study Reply to letter to the editor Edoardo FerlazzoSara GaspariniUmberto Aguglia Letter to the Editor 14 September 2022 Pages: 385 - 387
Predominant motor neuron involvement as a manifestation of pathogenic (full range) ATXN3 mutations Jarosław DulskiAlexandra Estela Soto PiñaZbigniew K. Wszolek Letter to the Editor 23 September 2022 Pages: 389 - 392
Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial Ali Amini HarandiHossein PakdamanMohammadali Sahraian Clinical Trial article 12 September 2022 Pages: 393 - 396
Anti-Tr/DNER antibody–associated cerebellar ataxia: three rare cases report and literature review Yun CaiJie LiuWeiying Di Clinical Trial article 12 September 2022 Pages: 397 - 403
Unilateral subcortical extensive dilated perivascular spaces associated with superior sagittal sinus perivenous dilated spaces Dimitri RenardGiovanni CastelnovoMarc Hackius Neuro-Images 13 September 2022 Pages: 405 - 407